Humanscape to Build the Finest Blockchain-based Patient Network in Asia

Food and Healthcare Press Releases Thursday August 2, 2018 15:03
SEOUL, South Korea--2 Aug--PRNewswire/InfoQuest
  • Direct sharing of symptoms and treatment processes and provision of compensation for the sharing of information.
  • Expected to release blockchain-based "Humanscape" later this year.

Today, more and more people are suffering from serious, incurable, and/or rare illnesses. However, access to information on such conditions has been quite limited, to hospitals or internet surfing. Even though there were communities and organizations serving people with certain illnesses, information was not widely available, due to the general nature of the illnesses.

Min-hoo Chang, the CEO of Humanscape, giving a speech at 'Blockchain Expo 2018' held in Amsterdam

Developing and implementing IT solutions in the healthcare sector for the past four years, Humanscape realized that there is a lack of proper health information platforms. They believed that providing an information exchange platform that gives patients complete control over their patients-generated health data (PGHD) and allowing pharmaceutical companies, doctors, and hospitals to utilize the data, will help us find new treatments and further improve existing treatments.

In addition, applying blockchain technology to such patient health data management will enable safe data exchange and storage. When patients record information on their illnesses via Humanscape, the information is encrypted and can only be used in designated areas. Additionally, patients will be compensated accordingly when they share information on the patient's platform. Min-hoo Chang, CEO of Humanscape, commented, "Since the simple act of sharing information can be so helpful for people suffering from rare and incurable diseases, we expect to see a high participation rate." Patients can exchange their compensation for cash. Humanscape Team is also planning on having various dApps (decentralized apps) to allow patients to purchase non-prescription, functional foods and medical equipment with its own currency earned as compensation.

The welcoming responses of patient organizations and pharmaceutical companies towards Humanscape exceeded its expectations. Chang commented, "Patient organizations that were in dire need of well-structured patients data have come to recognize the value of the Humanscape Project. Humanscape has signed MOUs with patient organizations for rare retina-related diseases, Korean Foundation Fighting Blindness and Amseungmo (one of the most well-known cancer patient communities), and is also discussing multi-faceted cooperation with many more." Chang also mentioned that, "Executives of global pharmaceutical companies that needed patient information on patients' medication, physical condition, and lifestyle, have joined Humanscape as advisors and are actively involved in the company's business activities."

Humanscape's long-term goal is to provide the best healthcare community service in Asia, especially in countries with poor medical services. To this end, the company has established a subsidiary in Indonesia and is currently establishing partnerships with local companies and hospitals. Furthermore, Humanscape is entering the Vietnamese market through the Ministry of SMEs and Startups' Global Expansion Program (GEP) with the support of the Chungnam Center for Creative Economy and Innovation.

Chang said, "There are relatively few patients with rare and incurable diseases, which makes it difficult for pharmaceutical companies to be active in this field. However, if a proper medicine is to be developed, it would be a blue ocean. In this context, if we are able to achieve our goal of creating the best patient community in Asia, I am certain that it will be beneficial to all."

Telegram:   https://t.me/Humanscape
Photo - https://photos.prnasia.com/prnh/20180802/2198737-1
Caption: Min-hoo Chang, the CEO of Humanscape, giving a speech at 'Blockchain Expo 2018' held in Amsterdam

Latest Press Release

APEC#s Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by 2025

- Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). - Aims to define, diagnose and...

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for...

Ascensia Diabetes Care Highlights the Support That Families Provide for People With Diabetes To Mark World Diabetes Day 2018

Today, Ascensia Diabetes Care, a global leading diabetes care company, launched their campaign for World Diabetes Day 2018 to celebrate the important role of families for people with diabetes. They are publishing 38 online artworks that tell the stories...

Qatar Foundation Ushers in New Era of Healthcare With Official Inauguration of Sidra Medicine

Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation (QF), today officially inaugurated Sidra Medicine - a brand new, world-leading women's and children's hospital in Qatar. The grand opening reflects the country's broader focus and...

Singapore National Eye Centre, Singapore Eye Research Institute And Johnson Johnson Vision Set Sights On Halting Global Myopia Epidemic

New US$26.35 Million Collaboration Seeks Prevention and Treatment Solutions to Address Rising Burden of Condition The Singapore National Eye Centre (SNEC), the Singapore Eye Research Institute (SERI) and Johnson & Johnson Vision today announced a...

Related Topics